Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

• Status: Completed
• Trial end date: 2009-01-14
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bromfenac; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Subjects 18 years of age or older

Exclusion Criteria:

• No active ocular conditions of disease